KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Current Assets (2016 - 2025)

Historic Current Assets for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $35.6 billion.

  • Bristol Myers Squibb's Current Assets rose 2691.01% to $35.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $35.6 billion, marking a year-over-year increase of 2691.01%. This contributed to the annual value of $29.8 billion for FY2024, which is 626.38% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Current Assets of $35.6 billion as of Q3 2025, which was up 2691.01% from $33.2 billion recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Current Assets high stood at $35.6 billion for Q3 2025, and its period low was $26.8 billion during Q3 2022.
  • Over the past 5 years, Bristol Myers Squibb's median Current Assets value was $29.2 billion (recorded in 2021), while the average stood at $29.6 billion.
  • In the last 5 years, Bristol Myers Squibb's Current Assets crashed by 1800.55% in 2022 and then skyrocketed by 2691.01% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Current Assets (Quarter) stood at $33.3 billion in 2021, then decreased by 18.01% to $27.3 billion in 2022, then increased by 16.49% to $31.8 billion in 2023, then dropped by 6.26% to $29.8 billion in 2024, then grew by 19.64% to $35.6 billion in 2025.
  • Its last three reported values are $35.6 billion in Q3 2025, $33.2 billion for Q2 2025, and $30.8 billion during Q1 2025.